Immunai and Boehringer Ingelheim have entered a multi-project collaboration to identify new T-cell targets in oncology and ...

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

A new study overturns long-held assumptions about the cause of the rare inflammatory disorder MKD, identifying a previously ...

A new study upends movement disorder research, proving Purkinje cells are a poor biomarker for deep cerebellar nuclei.

Landau, MD, discussed promising results of CAR T-cell therapy in light chain amyloidosis and the challenge of developing ...

Analysis of brain recordings revealed little correlation between two key cerebellar cell types, prompting a reassessment of ...

Cirius Therapeutics, Inc., a developer of innovative therapies for people suffering from diseases caused by mitochondrial dysfunction and insulin resistance, today announced enrollment and dosing has ...

The condition's impact extends beyond pigmentation loss, with links to thyroid disorders, diabetes, mental health challenges ...

Researchers at Virginia Tech's Fralin Biomedical Research Institute find activity in more easily accessible Purkinje cells in ...

A newly discovered brain peptide, AETA, may hold the key to detecting Alzheimer’s long before memory loss becomes visible.

Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...